feed,title,long_url,short_url
BioRxiv,"Stable nebulization and muco-trapping properties of Regdanvimab/IN-006 support its development as a potent, dose-saving inhaled therapy for COVID-19",https://biorxiv.org/cgi/content/short/2022.02.27.482162v1?rss=1,https://bit.ly/35nwLD4
